Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05190120 · ClinicalTrials.gov registry record · Phase 4
Adductor Canal Block Versus Femoral Block on Pain and Quadriceps Strength
A Phase 4 study of Anterior Cruciate Ligament Tear and Knee Meniscus Tear, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 132
- Enrollment target
- 1
- Study location
NCT05190120: Completed Phase 4 study of Anterior Cruciate Ligament Tear and Knee Meniscus Tear, sponsored by University of California, San Francisco.
NCT05190120 is a Phase 4 study of Anterior Cruciate Ligament Tear and Knee Meniscus Tear that has completed, run by University of California, San Francisco. The registered enrollment target is 132 participants, below the 218-participant average among 11 other Anterior Cruciate Ligament Tear trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05190120, a Phase 4 study of Anterior Cruciate Ligament Tear and Knee Meniscus Tear, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 132 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effects of a femoral nerve block vs. an adductor canal block on pain and quadriceps muscle strength for knee arthroscopy surgery.
Primary Outcome
Quadriceps strength will be tested with a dynamometer before the nerve block and 20 minutes after the nerve block prior to surgery. The dynamometer measures the strength of the quadriceps muscles in the seated position while pushing against the device. We are trying to measure the effect of both femoral and adductor canal nerve blocks on quadriceps strength.
Conditions Studied
Interventions
- PROCEDURE Femoral Nerve Block
- PROCEDURE Adductor Canal Nerve Block
- DRUG preoperative Femoral Nerve Block using 20ml of 0.5% ropivacaine
- DRUG Preoperative Adductor canal block with 0.75%% ropivacaine 13.3ml.
Study Locations (1)
California
- UCSF Orthopedic Trauma Service - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2016-01 |
| Est. Completion | 2022-03-20 |
| Phase | Phase 4 |
What the finished NCT05190120 record still lists
NCT05190120 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 218-participant average among 11 other Anterior Cruciate Ligament Tear trials with a reported enrollment target (39% lower).
The record links to 2 conditions, with Anterior Cruciate Ligament Tear appearing as the primary indexed condition, and to 4 interventions - of which Femoral Nerve Block is the first listed.
NCT05190120 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05190120 about?
NCT05190120 is a clinical study titled "Adductor Canal Block Versus Femoral Block on Pain and Quadriceps Strength". The purpose of this study is to compare the effects of a femoral nerve block vs. an adductor canal block on pain and quadriceps muscle strength for knee arthroscopy surgery.
What is the current status of trial NCT05190120?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 132 participants. The study started on 2016-01. Estimated completion is 2022-03-20.
What conditions does trial NCT05190120 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Tear, Knee Meniscus Tear.
What interventions are being tested in trial NCT05190120?
The interventions under investigation include: Femoral Nerve Block (PROCEDURE), Adductor Canal Nerve Block (PROCEDURE), preoperative Femoral Nerve Block using 20ml of 0.5% ropivacaine (DRUG), Preoperative Adductor canal block with 0.75%% ropivacaine 13.3ml. (DRUG).
Who is sponsoring clinical trial NCT05190120?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05190120 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05190120's enrollment target sits among peer trials
132 4th of 11 higher than 8 of 11 other Anterior Cruciate Ligament Tear trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anterior Cruciate Ligament Tear trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction
RECRUITING · Phase 4
-
Bridge-Enhanced ACL Repair-Safety Study (BEAR Trial)
ACTIVE NOT RECRUITING · NA
-
Bridge-Enhanced ACL Repair vs ACL Reconstruction
ACTIVE NOT RECRUITING · NA
-
Anterior Cruciate Ligament Reconstruction Hybrid Remnant Repair
ACTIVE NOT RECRUITING · NA
-
Tendon-Bone Versus All-Soft-Tissue for ACL Reconstruction: A Patient-Blinded Randomized Clinical Trial
ACTIVE NOT RECRUITING · NA
-
A Comparison of ACL Repair With BEAR Device vs. Autograft Patellar Tendon ACL Reconstruction
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia